products-page-bottom-left-box

Al-Tinez Hydrocortisone

Al-Tinez Pharmaceuticals Limited
9, Olowogbowo Str off Obokun Str by Coker Rd, Ilupeju, Lagos
Tel: 01-4826452; 0802-307-7320, 0803-305-7978

Brand Name

Al-Tinez Hydrocortisone

Manufacturer

Medipharco 8 Nguyen Truong To St., Hue City, Vietnam.

Therapeutic Class

Corticosteroids, Topical

Dosage Form, Composition & NAFDAC Registration Number (NRN)

Cream (NRN:A4-4419): Hydrocortisone acetate 200 mg.

Pack size: Tube of 20 g. Box of 1 tube.

Pharmacology

Topical corticosteroids have anti-inflammatory, anti-pruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear.

Various laboratory methods, including vasoconstrictor assays are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man.

Indications

Non-infected acute dermatitis or eczema, including infantile eczema, atopic eczema, contact and allergic dermatitis, otitis externa, nummular eczema, pruritus vulvae and pruritus ani, sunburn.

Contra-indications

Sensitivity to any of the ingredients of Al-Tinez Hydrocortisone.

Herpes and other viral diseases of the skin (vaccinia, smallpox, chickenpox), perioral dermatitis, tuberculosis or syphilitic skin disorders.

Systemic fungal infections.

Precautions/Warnings

  • It should not be applied to large body surface areas.
  • Suitable precautions should be taken under these conditions or when long-term use is anticipated, particularly in infants and children.
  • It should not be used continually over 8 days.
  • Do not use Al-tinez Hydrocortisone cream for the eyes.
  • Do not use for acne. Do not use under waterproof bandages.

Pregnancy and lactation:

Since safety of topical corticosteroid use in pregnant women has not been established. Drugs of this class should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Since it is not known whether topical administration of corticosteroids can result in sufficient systemic absorption to produce detectable quantities in breast milk, a decision should be made to discontinue based on the importance of the drug to the mother.

Interactions

Hydrocortisone reacts with a number of drugs, it is thus advisable to consult with your healthcare professional if you are taking any other medications along with hydrocortisone.

Adverse Effects

The following local adverse reactions have been reported infrequently with appropriate use of corticosteroid: Burning, itching, irritation, dryness, folliculitis, hypertrichosis, eruptions, allergic contact dermatitis, secondary infections, skin atrophy, striae and miliaria.

Inform your doctor of any adverse reaction related to drug use.

Dosage & Administration

Take under the instruction of physician.

Apply a thin film of the cream to cover completely the affected area twice daily, in the morning and at night. Stop treatment slowly.

Prolonged use of topical corticosteroid over 8 days is not recommended.

Storage/Handling Recommendations

Store in dry places, below 30ºC, protect from light.

Review Date

2016-12-02 07:20:17